| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 08/08/2001 | EP1121127A1 Oral pharmaceutical compositions containing buprenorphin |
| 08/08/2001 | EP1121126A1 Method for treating schizophrenia and means used in said method |
| 08/08/2001 | EP1121123A2 Formulations of fexofenadine |
| 08/08/2001 | EP1121120A1 Use of ophthalmic composition comprising vitamin a and vitamin e |
| 08/08/2001 | EP1121117A2 Oxaliplatinum preparation packaging |
| 08/08/2001 | EP1121116A2 Sustained release pharmaceutical composition and method of releasing pharmaceutically active agent |
| 08/08/2001 | EP1121112A2 Storable active substance concentrate with formoterol |
| 08/08/2001 | EP1121109A2 Opioid analgesic |
| 08/08/2001 | EP1121107A2 Sertraline oral concentrate |
| 08/08/2001 | EP1121104A2 New sustained release oral formulations |
| 08/08/2001 | EP1121103A2 Orally disintegrable tablets |
| 08/08/2001 | EP1121102A1 Liposome-entrapped topoisomerase inhibitors |
| 08/08/2001 | EP1121101A1 Aerosol ointment compositions and method of manufacture |
| 08/08/2001 | EP1121100A1 Method for preparing a solution for nasal spray containing sex hormones and a cyclodextrin |
| 08/08/2001 | EP1121099A1 Pharmaceutical composition with gastric residence and controlled release |
| 08/08/2001 | EP1121088A1 Use of nanoscale sterols and sterol esters |
| 08/08/2001 | EP1054595A4 Methods and compounds for the genetic treatment of hyperlipidemia |
| 08/08/2001 | EP1044005A4 1,2,4-benzotriazine oxides formulations |
| 08/08/2001 | EP1037647B1 Medicinal plant dry extracts |
| 08/08/2001 | EP1024792A4 Topical antifungal composition |
| 08/08/2001 | EP1019037B1 Medicament containing delta-aminolevulinic acid |
| 08/08/2001 | EP0965342B1 Preparation for percutaneous administration containing 6-amino-5-chloro-1-isopropyl-2-(4-methyl-1-piperazinyl)benzimidazole |
| 08/08/2001 | EP0920304B1 Method for the production of a granulate for hemodialysis |
| 08/08/2001 | EP0831779B1 Process for making liposome preparation |
| 08/08/2001 | EP0759773B1 Lacrimal gland specific emulsions for topical application to ocular tissue |
| 08/08/2001 | EP0739197B1 Preserved ophthalmic drug compositions containing polymeric quaternary ammonium compounds |
| 08/08/2001 | EP0702959B1 Cross-linked gelatin gel preparation containing basic fibroblast growth factor |
| 08/08/2001 | EP0641223B1 Biotherapeutic cell-coated microspheres |
| 08/08/2001 | CN1307613A Coating and excipient agent for oral or dermal dosage forms |
| 08/08/2001 | CN1307522A Multi-action particle for structuring biological media |
| 08/08/2001 | CN1307490A Synthetic biomaterial compound |
| 08/08/2001 | CN1307486A Pharmaceutical levothyroxine preparation |
| 08/08/2001 | CN1307476A Sustained release oral preparations of fasudil hydrochloride |
| 08/08/2001 | CN1307475A Medicinal compositions |
| 08/08/2001 | CN1307472A Compositions comprising organic mono-or dinitrate for treating impotence |
| 08/08/2001 | CN1307470A Pharmaceutical formulations for aerosols with two or more active substances |
| 08/08/2001 | CN1306862A Matrix for Chinese medicine plaster and its preparation technology |
| 08/08/2001 | CN1306852A Preparation method of tablet, yranule and capsule of single Chinese medicine material |
| 08/08/2001 | CN1306842A Preparation of shaolin plaster for rheumatism and wound |
| 08/08/2001 | CN1306841A Preparation of bone-strengthening musk plaster |
| 08/08/2001 | CN1306828A Ointment for treating rheumatism |
| 08/08/2001 | CN1306825A Adsorbed burn ointment |
| 08/08/2001 | CN1306822A Medicament for treating dermatosis and its preparation |
| 08/08/2001 | CN1306818A Medicine for treating abacterial inflammation and its extraction method |
| 08/08/2001 | CN1306817A Antiseptic caries-preventing chewing gum |
| 08/08/2001 | CN1069217C Immune serum globulin for intravenous injection and preparing method thereof |
| 08/08/2001 | CN1069214C Stabilized somatotropin for parenteral administration |
| 08/08/2001 | CN1069212C Rheumatism plaster |
| 08/08/2001 | CN1069211C Gastrosis plaster |
| 08/08/2001 | CN1069210C Liquid for curing scald and burn and its preparing method |
| 08/08/2001 | CN1069201C Liquid for stopping smoking and making method thereof |
| 08/08/2001 | CN1069200C Medicine made from plum and apricot and production method thereof |
| 08/08/2001 | CN1069197C Pharmaceutical formulation containing dirithromycin |
| 08/08/2001 | CN1069195C Prep. of suspendible composition |
| 08/08/2001 | CN1069194C Combined construction method of concretepouring and grouting for inclined shafts and vertical shafts |
| 08/08/2001 | CN1069193C Prep. of ointments containing tricyclic compound |
| 08/08/2001 | CN1069192C Aerosol preparation and preparation method thereof |
| 08/08/2001 | CN1069191C Compressed gas packagings using polyoxyethylene glyleryl oleates description |
| 08/08/2001 | CN1069169C Applying formulations containing glycols and/or glycerides |
| 08/07/2001 | US6271615 Brush holder |
| 08/07/2001 | US6271307 Drugs with polyether copolymers with unsaturated ester, vinyl ethers, amides or acids |
| 08/07/2001 | US6271268 Treatment of gland disorders with antisecretory agents such as acyl coa cholesterol acyl transferase(acat) inhibitors or prodrugs |
| 08/07/2001 | US6271243 Pharmaceutical composition |
| 08/07/2001 | US6271240 Prolonged, controlled administration of nalmefene, coadministered with bupropion, in steady state plasma concentration; achieved via sustained release delivery system (transdermal patch) |
| 08/07/2001 | US6271224 Vision defects |
| 08/07/2001 | US6271219 Topical formulations comprising skin penetration agents and the use thereof |
| 08/07/2001 | US6271216 Stable solution of hyaluronate in a balanced salt medium |
| 08/07/2001 | US6271211 Muscle contraction |
| 08/07/2001 | US6271209 Cationic lipid formulation delivering nucleic acid to peritoneal tumors |
| 08/07/2001 | US6271208 Mixing, particle sizing |
| 08/07/2001 | US6271206 Stabilization; drug delivery |
| 08/07/2001 | US6271200 Proteinic drug delivery system using aerosolized membrane-mimetic amphiphiles |
| 08/07/2001 | US6271196 Polypeptide |
| 08/07/2001 | US6271001 Cultured plant cell gums for food, pharmaceutical, cosmetic and industrial applications |
| 08/07/2001 | US6270807 Taste-masked pharmaceutical composition |
| 08/07/2001 | US6270806 Use of peg-derivatized lipids as surface stabilizers for nanoparticulate compositions |
| 08/07/2001 | US6270805 Two pellet controlled release formulation for water soluble drugs which contains an alkaline metal stearate |
| 08/07/2001 | US6270804 Sachet formulations |
| 08/07/2001 | US6270803 Granulated garlic particles which have been microencapsulated by direct coating with an enteric coating and at least one pharmaceutically acceptable diluent, adjuvant or excipient therefor. |
| 08/07/2001 | US6270802 Which can easily be maintained aseptic throughout all stages of the production process. |
| 08/07/2001 | US6270801 Apparatus and a method for treating particulate materials |
| 08/07/2001 | US6270800 Aqueous solvent based encapsulation of a bovine herpes virus type-1 subunit vaccine |
| 08/07/2001 | US6270799 1-cyclopropyl-7-((s,s)-2,8-diazabicyclo(4.3.0)non-8-yl)-6-fluo ro-1, 4-dihydro-8-methoxy-4-oxo-3-quino-lonecarboxylic acid and/or pharmaceutically tolerable salts |
| 08/07/2001 | US6270798 Drug particles have first coating controlling the release of the drug and a second outer coating with saliva-resistant properties |
| 08/07/2001 | US6270797 Sustained release pharmaceutical composition containing glipizide and method for producing same |
| 08/07/2001 | US6270796 Antihistamine/decongestant regimens for treating rhinitis |
| 08/07/2001 | US6270795 Method of making microencapsulated DNA for vaccination and gene therapy |
| 08/07/2001 | US6270793 Hydratable keratin solid wherein said hydratable keratin comprises keratin having sulfonic acid groups ionically associated with monovalent cations. |
| 08/07/2001 | US6270791 Soluble keratin peptide |
| 08/07/2001 | US6270790 Mannitol, sorbitol, maltitol, dextrose, sucrose, xylitol, or lactose; cellulose, cellulosic derivatives, polyvinyl pyrrolidone, starch, ormodified starch binder |
| 08/07/2001 | US6270789 Comprising (a) oily or fatty base, (b) polyethylene and (c) polyglycerin fatty acid ester. |
| 08/07/2001 | US6270787 Osmotic delivery system with membrane plug retention mechanism |
| 08/07/2001 | US6270770 Production losses can be prevented by a live attenuated caa vaccine for mucosal administration. |
| 08/07/2001 | US6270769 Providing the antigen to which the ctl response is desired and providing an antigen formulation which consists of two or more of a stabilizing detergent, a micelle-forming agent, and an oil; antigen lacking an immunostimulating peptide component |
| 08/07/2001 | US6270752 Based on essential oils obtainable through alcoholic distillation of plants which contain the essential oils, combined with salicylic acid and with fatty acids having 10 to 40 carbon atoms. |
| 08/07/2001 | US6270747 Inhibiting hypersecretion of mucus in lungs and airways by the administration of an egf-r antagonist. |
| 08/07/2001 | US6270700 Encapsulation of water soluble peptides |
| 08/07/2001 | CA2242748C Hair conditioning compositions |
| 08/07/2001 | CA2222613C A device for delivering a preselected molecule into systemic circulation |
| 08/07/2001 | CA2211006C Topically applied pharmaceutical composition, method of preparing it and its use |